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In Rhizobium-legume symbiosis, the bacteria are converted into nitrogen-fixing
bacteroids. In many legume species, differentiation of the endosymbiotic bacteria
is irreversible, culminating in definitive loss of their cell division ability. This terminal
differentiation is mediated by plant peptides produced in the symbiotic cells. In
Medicago truncatula more than ∼700 nodule-specific cysteine-rich (NCR) peptides are
involved in this process. We have shown previously that NCR247 and NCR335 have
strong antimicrobial activity on various pathogenic bacteria and identified interaction of
NCR247 with many bacterial proteins, including FtsZ and several ribosomal proteins,
which prevent bacterial cell division and protein synthesis. In this study we designed
and synthetized various derivatives of NCR247, including shorter fragments and
various chimeric derivatives. The antimicrobial activity of these peptides was tested
on the ESKAPE bacteria; Enterococcus faecalis, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia
coli as a member of Enterobacteriaceae and in addition Listeria monocytogenes and
Salmonella enterica. The 12 amino acid long C-terminal half of NCR247, NCR247C
partially retained the antimicrobial activity and preserved the multitarget interactions
with partners of NCR247. Nevertheless NCR247C became ineffective on S. aureus,
P. aeruginosa, and L. monocytogenes. The chimeric derivatives obtained by fusion of
NCR247C with other peptide fragments and particularly with a truncated mastoparan
sequence significantly increased bactericidal activity and altered the antimicrobial
spectrum. The minimal bactericidal concentration of the most potent derivatives was
1.6 µM, which is remarkably lower than that of most classical antibiotics. The killing
activity of the NCR247-based chimeric peptides was practically instant. Importantly,
these peptides had no hemolytic activity or cytotoxicity on human cells. The properties
of these NCR derivatives make them promising antimicrobials for clinical use.
Keywords: antimicrobial peptides, plant symbiotic nodule-specific cysteine-rich peptides, NCR247, ESKAPE
bacteria, modes of antimicrobial activity, killing kinetics, bacterial targets, antibiotics
Frontiers in Microbiology | www.frontiersin.org 1 February 2020 | Volume 11 | Article 270
fmicb-11-00270 February 20, 2020 Time: 20:14 # 2
Jenei et al. Plant Peptides Kill ESKAPE Bacteria
INTRODUCTION
The world-wide spread of antibiotic resistant bacteria and the
increasing mortality rate by untreatable microbial infections
make the development of new antibiotics with novel modes
of actions and less prone to development of resistance
extremely urgent. Plant peptides, produced only in Rhizobium
bacterium-legume symbiosis, in the symbiotic cells of root
nodules, represent a rich source of so far unexplored biological
activities and antimicrobial agents. The infected nodule cells
contain thousands of bacteria that are encapsulated by plasma
membrane derived vesicles, forming organelle-like structures,
called symbiosomes. In the host cells the bacteria adapt
to the intracellular life-style, microaerobic conditions and
differentiate progressively into nitrogen-fixing bacteroids. In
many legumes, this differentiation process is irreversible, and
manifested by extreme cell growth, altered morphology and
physiology, genome amplifications and definitive loss of cell
division potential (Kondorosi et al., 2013). We described this
terminal differentiation process first in Medicago truncatula and
demonstrated that it is controlled by the host plant (Mergaert
et al., 2006). We discovered an entirely new peptide family which
has evolved only in those legumes where the endosymbionts’
differentiation is terminal (Mergaert et al., 2003; Van de Velde
et al., 2010). In M. truncatula, ∼700 genes code for nodule
specific cysteine rich NCR peptides (Montiel et al., 2017; de
Bang et al., 2017). The NCR genes usually consist of two
exons; the first coding for a relatively conserved signal peptide,
while the second one for the mature peptide. The mature NCR
peptides exhibit extreme differences in their physicochemical
properties due to their highly divergent amino acid compositions
and sequence where only the position of 4 or 6 cysteines
and a few neighboring amino acids is conserved. The NCR
peptides enter the endoplasmic reticulum during their translation
where the signal peptidase complex cleaves the signal peptide
and the mature peptides reach the symbiosomes via the Golgi
transport vesicles. NCR peptides can interact with the bacterial
cell envelope, the bacterial membranes and with specific targets
in the bacterial cytosol by entering the cells.
NCR247, which is the smallest peptide of the NCR family,
is composed of 24 amino acids, four of which are cysteines.
This cationic peptide (pI 10.15) is a self-penetrating peptide
entering the bacterial cytosol without pore formation, which
has exceptionally high protein binding ability and interacts with
many bacterial proteins (Farkas et al., 2014). It binds to the
conserved cell division protein FtsZ and abolishes the FtsZ ring
formation and thereby bacterial cell division. NCR247 interacting
with many ribosomal proteins inhibits translation but also
downregulates the transcription of ribosomal genes. Accordingly,
treatment of various pathogenic bacteria with synthetic NCR247
provoked efficient killing of many of them (Tiricz et al., 2013).
In this work, we studied the antimicrobial activity of
NCR247 and its derivatives on the most problematic ESKAPE
bacteria, Enterococcus faecalis, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa,
and Escherichia coli as well as Listeria monocytogenes and
Salmonella enterica. We tested which region of NCR247 is
responsible for the antibacterial activity and how this activity and
antimicrobial spectrum can be further enhanced by fusion with
neutral or other antimicrobial peptide (AMP) fragments. We
show that the designed chimeric peptides act very fast and in at
least as low or even lower concentrations than levofloxacin (Lvx)
and orders of magnitude lower concentrations than carbenicillin
(Cb). None of the five potent chimeric peptides provoked
hemolysis of human erythrocytes or killed human cells, which
makes them very promising antimicrobial candidates.
MATERIALS AND METHODS
Bacterial Strains
The pathogenic bacterial strains obtained from the ATCC
(United States) and NCTC (National Collection of Type
Cultures – England) were the Gram-positive: Enterococcus
faecalis (ATCC 29212), Staphylococcus aureus (HNCMO112011),
Listeria monocytogenes (ATCC 19111) and the Gram-negative:
Pseudomonas aeruginosa (ATCC 27853), Escherichia coli (ATCC
8739), Salmonella enterica (ATCC 13076), Klebsiella pneumoniae
(NCTC 13440), Acinetobacter baumannii (ATCC 17978).
Antimicrobial Activity in 20 mM
Potassium-Phosphate Buffer, pH 7.4
(PPB)
Overnight bacterial cultures grown in LB were diluted and grown
to OD600 = 0.2–0.6 at 37◦C with shaking. After harvesting
and washing bacteria in PPB, the suspensions were adjusted to
OD600 = 0.1 corresponding to ∼107 bacteria/mL. Antimicrobial
activity of the peptides and the antibiotics was determined in
PPB in 96 well microplates using 10 µL bacterial suspension and
90 µL of the 2-fold serial dilutions of peptides or antibiotics.
Peptides were tested from 25 µM to 0.125 µM whereas
the antibiotics; carbenicillin (Cb) from Duchefa Biochemie
(Prod.No. C0109.0025) and levofloxacin (Lvx) from Sigma-
Aldrich (Prod.No. 28266-10MG-F) from 10.24 mM to 0.1 µM.
The microplates were incubated for 3 h at 37◦C with 250 rpm
shaking and then 5 µl from each sample was placed on
LB agar and the growth of bacteria was monitored after
overnight incubation at 37◦C. The lowest concentration of the
antimicrobial agents, which completely eliminated viable bacteria
was the minimal bactericidal concentration (MBC).
Antimicrobial Activity in Mueller Hinton
Broth (MHB)
Ca2+ and Mg2+ can inhibit the antimicrobial activity of
cationic peptides, therefore the MBC and MIC values were also
determined in MHB, which unlike PPB contains divalent cations
and allows growth of bacteria. Bacteria were grown and prepared
similarly except that bacteria were resuspended in MHB. 10 µl
of bacteria OD600 = 0.1, supplemented with 45 µl MHB and
45 µl of 2-fold dilution series of peptides, were cultivated for
3 and 20 h at 37◦C with shaking. Optical density of each
sample was measured (Hidex Sense Microplate Reader with
Plate Reader Software version 5064) and 5 µl was placed on LB
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TABLE 1 | List of antimicrobial peptides.
Code Name Amino acid sequence pI
A NCR247 RNGCIVDPRCPYQQCRRPLYCRRR 10.15
B NCR247C QQCRRPLYCRRR 11.50
C NCR247C-StrepII QQCRRPLYCRRRWSHPQFEK 11.05
D X1-NCR247C RPLNFKMLRFWGQQQCRRPLYCRRR 11.99
E X1-NCR247C-StrepII RPLNFKMLRFWGQQQCRRPLYCRRRWSHPQFEK 11.80
F NCR247C-X2 QQCRRPLYCRRRKALAALAKKIL 11.55
G NCR247C-X2-StrepII QQCRRPLYCRRRKALAALAKKILWSHPQFEK 11.40
H X2-NCR247C KALAALAKKILQQCRRPLYCRRR 11.65
I X2 KALAALAKKIL 10.98
J Transportan GWTLNSAGYLLGKINLKALAALAKKIL 10.77
agar plates after 3 and 20 h treatment. The minimal inhibitory
concentration (MIC) corresponded to the lowest concentration,
which inhibited growth.
Chemical Synthesis of Peptides
The antimicrobial peptides (AMPs) listed in Table 1 were
synthesized according to the standard procedure of the
solid-phase peptide synthesis (SPPS) by using an automatic
peptide synthesizer (CEM Liberty Blue) with TentaGel S RAM
resin (loading of amino groups −0.23 mmol/g). The applied
chemistry utilized the Fmoc amino protecting group and
diisopropylcarbodiimide/oxyma coupling with a fivefold excess
of reagents. Removal of the fluorenyl-9-methoxycarbonyl (Fmoc)
group was carried out with 10% piperazine and 0.1 mol 1-
hydroxy-benzotriazole (HOBt) dissolved in 10% ethanol and 90%
DMF in two cycles. After completion of the synthesis, peptides
were detached from the resin with a 95:5 (v/v) trifluoroacetic acid
(TFA)/water mixture containing 3% (w/v) dithiothreitol (DTT)
and 3% (w/v) triisopropylsilane (TIS) at room temperature (RT)
for 3 h. The resin was removed by filtration and the peptides were
precipitated by the addition of ice cold diethyl ether. Next, the
precipitate was filtered, dissolved in water and lyophilized. The
crude peptides were analyzed and purified by reverse-phase high-
performance liquid chromatography (RP-HPLC). Peptides were
purified using a C18 column with a solvent system of (A) 0.1%
(v/v) TFA in water and (B) 80% (v/v) acetonitrile and 0.1% TFA
(v/v) in water at a flow rate of 4.0 mL/min. The absorbance was
detected at 220 nm. The appropriate fractions were pooled and
lyophilized. Purity of the peptides was characterized by analytical
RP-HPLC at a flow rate of 1.0 mL/min. The identity of the
peptides was verified by ESI-MS using Waters SQ detector.
Identification of the Interacting Bacterial
Partners of NCR247C-X2-StrepII
Logarithmic phase E. coli bacteria (OD600 = 0.6) grown
in LB were harvested by centrifugation, washed and re-
suspended in PPB. Separation of the membrane and cytosolic
proteins was done by ultracentrifugation according to Sandrini
et al. (2014). Briefly, bacteria were sonicated and large debris
removed by centrifugation. The membrane proteins (pellet)
and the cytoplasmic proteins (supernatant) were separated by
ultracentrifugation of the supernatant at 110000 g for 10 min
at 4◦C. NCR247C-X2-StrepII (peptide G, Table 1) or StrepII
was added at 0.02 mM concentration to the membrane or
cytosolic protein extract. These protein samples were incubated
together with Strep-Tactin Sepharose beads (IBA Lifesciences
Cat.No. 2-1201-010) for 90 min with gentle shaking on ice.
Affinity chromatography of protein complexes was carried out
according to the manual. Briefly, after the incubation, each
column was washed seven times with washing buffer (100 mM
Tris–HCl pH 8.0, 150 mM NaCl, 1 mM EDTA) and the
bound proteins were eluted with elution buffer (100 mM
Tris–HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 2.5 mM
desthiobiotin). The 2nd and 3rd elution fractions (E2, E3) were
separated with electrophoresis on 4–20% precast denaturing
gel (Bio-Rad Laboratories Cat.No. 456-1093) and visualized
with silver staining. Proteins were identified from E3 with
mass spectrometry. Guanidine hydrochloride was added to the
elution fractions to a final concentration of 6 M. The disulfide
bridges were reduced by 10 mM Tris(2-carboxyethyl)phosphine
(TCEP), then free sulfhydryls modified by 20 mM S-methyl
methanethiosulfonate (MMTS). After dilution of the samples
0.5 µg trypsin was added for an overnight digestion at 37◦C.
The digests were desalted on Varian OMIX C18 tips and dried.
An aliquot of the digests was subjected to LC-MS/MS analysis
on an Orbitrap Fusion Lumos Tribrid (Thermo Fisher Scientific)
mass spectrometer on-line coupled to a Waters M-Class UPLC
using HCD fragmentation. The peak lists generated by Protein
Discoverer (v1.4.) were subjected to database search using
Protein Prospector (v5.22.0) against E. coli entries in the
Uniprot.2019.6.12 database (1618419 entries).
Hemolysis and Cytotoxicity Assays
To evaluate possible side effects of the NCR247-based peptides,
hemolysis and cytotoxicity assays were performed. Human blood
was purchased from the Regional Blood Centre in Szeged. The
use of human blood for the hemolysis assay has been authorized
by the Regional Hungarian Ethics Committee and approved by
the Ethics Review Sector of DG RTD (European Commission)
in connection with EK’s ERC AdG SymBiotics. The cells from
1.2 mL of EDTA-blood were centrifuged at 1500 × g for 1 min
and washed several times in TBS buffer (10 mM Tris, pH = 7.2,
150 mM NaCl) until the supernatant became colorless. The
cells were then resuspended in 12 mL TBS buffer. 100 µL of
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this cell suspension was incubated with 100 µL of the peptides
at 100 and 25 µM. Samples were incubated for 1 h at 37◦C,
and after centrifugation of the cells at 1500 g for 1 min, the
supernatants were transferred into sterile 96-well plates and
the hemoglobin release was measured at OD560 (Multiskan FC
microplate reader, Thermo Fisher Scientific). Melittin (Bachem)
at 50 µg/mL and TBS without peptides were used as positive and
negative controls, respectively. Relative hemolytic activity (RHA)
of each peptide was calculated as follows: (Compound OD560
−TBS OD560)× 100/(Melittin OD560 −TBS OD560).
The cytotoxicity of peptides X1-NCR247C and NCR247C-
X2 was determined against the human melanoma A375 cells
with XTT cell proliferation assay kit (PanReac Applichem) and a
benchtop microplate reader (Multiskan RC, Thermo Labsystems)
according to the manufacturers’ instructions. A375 human
melanoma cell line was obtained from ATCC and maintained
in DMEM (Lonza) supplemented by 10% FBS (Euroclone) in
a humidified incubator at 37◦C and 5% CO2. A375 cells were
seeded to 96-well plates (4,000 cells/well) and treated with the
peptides for 72 h. Cells without peptides served as negative
control and the blank sample was the medium. Reduction of the
tetrazolium salt XTT by the viable cells to the orange colored
compounds of formazan was measured at OD450. The XTT assay
was performed in three biological repeats.
RESULTS
NCR247 and Its Derivatives Are Potent
Killers of Pathogenic Bacteria
Previously we have shown bactericidal activity of the synthetic
NCR247 peptide in PBS on several human and plant pathogen
bacteria (Tiricz et al., 2013). Our present work is focused on
the activity of NCR247 and its various derivatives (Table 1)
on the ESKAPE strains as well as on L. monocytogenes and
S. enterica. Bacterial cultures were treated with 2-fold dilution
series of synthetic NCR247 (peptide A, Table 1) starting with
25 µM concentration. The minimal bactericidal concentration
(MBC) was the lowest concentration of the tested molecules
where no viable bacteria remain after the treatment and therefore
the growth of bacteria could not be detected (Table 2). The killing
activity of NCR247 was the strongest with a MBC of 3.1 µM on
P. aeruginosa while the MBC was 6.3 µM in the case of S. aureus
and E. coli, 12.5 µM for A. baumannii and 25 µM for S. enterica.
K. pneumoniae, and L. monocytogenes were resistant at 25 µM to
NCR247 (peptide A, Table 2).
Then we tested which region of NCR247 is responsible for
the antimicrobial properties. From the 24 amino acid long
NCR247, the 12 amino acid long N-terminal and the 12 amino
acid long C-terminal halves were synthetized. The N-terminal
part (RNGCIVDPRCPY) was inactive on the tested bacteria,
while the C-terminal part (peptide B: NCR247C, Table 1)
retained the antimicrobial activity of NCR247 on E. coli (peptide
B, Table 2) but was ineffective to kill the other bacteria at
25 µM concentration.
The synthetic, reduced and even the oxidized forms of
NCR247 seems to be unstructured (Shabab et al., 2016). However,
TABLE 2 | Minimal bactericidal concentrations (MBC; in µM) of the studied
peptides and antibiotics against different pathogens after 3 h of treatment in PPB.
Peptides/
Antibiotics
E. f. S. a. K. p. A. b. P. a. E. c. L. m. S. e.
A >25 6.3 >25 12.5 3.1 6.3 >25 25
B >25 >25 >25 25 25 6.3 >25 >25
C >25 6.3 >25 25 6.3 6.3 >25 >25
D 6.3 3.1 12.5 3.1 3.1 3.1 3.1 1.6
E 12.5 3.1 6.3 3.1 3.1 3.1 3.1 3.1
F 25 3.1 6.3 3.1 3.1 1.6 1.6 1.6
G 12.5 1.6 3.1 1.6 3.1 1.6 3.1 1.6
H 3.1 3.1 6.3 3.1 3.1 3.1 3.1 3.1
I >25 25 >25 25 6.3 >25 25 >25
J 3.1 3.1 3.1 1.6 3.1 3.1 3.1 1.6
Cb 5120 640 >10240 5120 10240 1280 80 640
Lvx 160 2.5 320 20 1.3 5.0 320 1.3
E. f., Enterococcus faecalis; S. a., Staphylococcus aureus; K. p., Klebsiella
pneumoniae; A. b., Acinetobacter baumannii; P. a., Pseudomonas aeruginosa;
E. c., Escherichia coli; L. m., Listeria monocytogenes; S. e., Salmonella enterica.
Cb, carbenicillin; Lvx, levofloxacin.
it cannot be excluded that NCR247 might be properly folded
by interacting with the bacterial membranes, which may not be
possible if the peptide is only 12 amino acid long. Therefore, we
synthetized derivatives of the NCR247C peptide adding either
C- or N-terminal extension. First, the neutral, 8 amino acid long
StrepII tag (WSHPQFEK) was added to the C terminus (peptide
C: NCR247C-StrepII, Table 1). The StrepII was chosen because
in our previous study this tag did not harm the antimicrobial
activity of NCR247 and it was used for pull down experiments
to identify its bacterial targets (Farkas et al., 2014). NCR247C-
StrepII became more active than NCR247C killing in addition to
E. coli, S. aureus, and P. aeruginosa (peptide C, Table 2).
Then the N-terminus of NCR247C was extended with 13
amino acids (X1) deriving from the cationic N-terminal part
of the unusual double size NCR335 which part lacks cysteines
and characteristics of NCRs but increased the pI from 10.15
to 11.99 (peptide D, Table 1). This chimeric peptide (X1-
NCR247C) turned out to be very effective on S. enterica (MBC
1.6 µM), S. aureus, A. baumannii, P. aeruginosa, E. coli, and
L. monocytogenes (MBC 3.1 µM) and became able to kill
E. faecalis (MBC 6.3 µM) and K. pneumoniae (MBC 12.5 µM)
(peptide D, Table 2). Addition of StrepII to the C terminus of
X1-NCR247C (peptide E: X1-NCR247C-StrepII, Table 1) slightly
improved the bactericidal property against K. pneumoniae but
became somewhat less efficient against E. faecalis and S. enterica
(peptide E, Table 2).
Thereupon, we investigated how attachment of another
AMP at the C- or N-terminus of NCR247C could influence
the bactericidal efficiency and spectrum. We used the
KALAALAKKIL sequence (peptide I: X2, Table 1) from
the membranolytic, anti-cancer mastoparan peptide toxin from
wasp venom (INLKALAALAKKIL), which is also present in the
C-terminus of the 27 amino acid long cell-penetrating cationic
peptide, transportan (peptide J: Transportan, Table 1) (Pooga
et al., 1998). Attachment of KALAALAKKIL to the C-terminus
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of NCR247C (peptide F: NCR247C-X2, Table 1) reduced the
MBC to 1.6 µM in the case of E. coli, L. monocytogenes, and
S. enterica (peptide F, Table 2). Further elongation of NCR247C-
X2 with StrepII (peptide G: NCR247C-X2-StrepII, Table 1)
made this derivative even more effective against S. aureus and
A. baumannii (MBC 1.6 µM) (peptide G, Table 2). Addition of
X2 to the N-terminal of NCR247C (peptide H: X2-NCR247C,
Table 1) drastically increased the killing of E. faecalis and was
the most active one (MBC 3.1 µM) among all tested peptide
derivatives (peptide H, Table 2). X2 alone was incomparably less
active on all tested bacteria (peptide I, Table 2). On the other
hand transportan effectively killed all bacteria with MIC in the
range of 1.6–3.1 µM (peptide J, Table 2).
The Antimicrobial Potential of NCR247
Based Peptides Is Comparable to
Third-Generation Antibiotics
To evaluate the effectiveness of these peptides compared to
antibiotics, we determined the MBC values of two antibiotics
under the same experimental conditions, after 3 h treatments
in PPB. One of them was the classical bactericidal antibiotic
carbenicillin, belonging to the carboxypenicillin subgroup of the
penicillins. The other one was levofloxacin, a third-generation,
fluoroquinolone antibiotic. The MBCs of both antibiotics showed
great variations on the tested bacteria (Table 2). Carbenicillin,
except for L. monocytogenes, was required in the range of 640 –
10240 µM while levofloxacin was active at 1.25 – 320 µM,
comparable to the chimeric NCR247C derivatives. Levofloxacin
was particularly effective against P. aeruginosa, S. enterica, and
S. aureus but the MBCs against K. pneumoniae, L. monocytogenes,
and E. faecalis were one or two orders of magnitude higher than
that of the chimeric NCR peptides.
The time dependence of bacterial killing was a further
question, which act faster: the peptides or the antibiotics?
The kinetics of bacterial killing was studied on S. aureus,
A. baumannii, and E. coli treated with MBC of each antimicrobial
molecule (peptide or antibiotic) (Figure 1 and Supplementary
Table S1). All chimeric peptides (D-H) killed all tested bacteria
either instantly or within 5 min. The killing by NCR247 and its
short derivatives (A-C) was slower but they eliminated E. coli in
20 min and A. baumannii in 30 min while viable cell number
of S. aureus was only slightly reduced in line with insensitivity
of S. aureus to the A–C peptides. Carbenicillin and levofloxacin
exhibited a much more protracted killing effect than the NCR247-
based peptides with large numbers of viable cells at 60 min
(Supplementary Table S1). Based on this data, it is clear that
particularly the chimeric peptides (D-H) kill bacteria much faster
than the tested antibiotics.
Bactericidal Activity of the Chimeric
NCR247 Based Peptides Is Maintained in
Mueller Hinton Broth
Antimicrobial activity of cationic peptides is generally attenuated
by the presence of divalent cations and higher salt concentrations
(Hancock and Sahl, 2006). Therefore we determined the MBC
and the minimal inhibitory concentration (MIC) values of all
peptides (A-J) in MHB used for the cultivation of S. aureus, A.
baumannii, and E. coli (Table 3). Peptides A-C, corresponding
to NCR247, NCR247C and NCR247C-StrepII were ineffective
against the three bacteria cultivated for 3 or 20 h at 25 µM
concentration. Growth inhibition was only detectable in the case
of A: NCR247 at 25 µM on E. coli cultivated for 20 h. Unlike
A-C, the D-H peptides retained their activity in MHB. Action of
D and E was, however, slowed down, as their MBC values were
significantly higher at 3 h than at 20 h. In contrast, the MBC
values of peptides F, G and H were identical or almost the same
at 3 and 20 h. Moreover in line with fast action of these peptides,
the MIC and MBC values were practically identical.
The Chimeric Peptide G:
NCR247C-X2-StrepII Interacts With
Many E. coli Proteins
Peptide G was one of the most active chimeric peptides, which
via its StrepII tag attached to the C-terminus of NCR247C-
X2, was used in pull-down experiments for the isolation of
FIGURE 1 | Time-kill kinetic analysis of antibiotics and the designed peptides. The number of colony forming units (CFU) is shown at 0.0, 0.1, 1, 2, 5, 10, 20, and
30 min of treatment.
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TABLE 3 | Minimal bactericidal concentrations (MBC) and minimal inhibitory concentrations (MIC) of the studied peptides in Mueller Hinton Broth on selected pathogens.
(A)
S. a. A. b. E. c.
A > 25 > 25 > 25
B > 25 > 25 > 25
C > 25 > 25 > 25
D 25 6.3 12.5
E 25 12.5 25
F 3.1 3.1 3.1
G 6.3 3.1 3.1
H 6.3 6.3 6.3
I > 25 > 25 > 25
J 6.3 3.1 6.3
(B)
S. a. A. b. E. c.
A >25 >25 >25
B >25 >25 >25
C >25 >25 >25
D 3.1 3.1 3.1
E 6.3 6.3 6.3
F 3.1 3.1 3.1
G 6.3 3.1 3.1
H 3.1 3.1 6.3
I >25 >25 >25
J 3.1 3.1 6.3
(C)
S. a. A. b. E. c.
A >25 >25 25
B >25 >25 >25
C >25 >25 >25
D 3.1 3.1 3.1
E 6.3 6.3 6.3
F 3.1 3.1 3.1
G 3.1 3.1 3.1
H 3.1 3.1 6.3
I >25 25 >25
J 3.1 3.1 3.1
(A) MBC (µM) – 3 h treatment, (B) MBC (µM) – 20 h treatment, and (C) MIC (µM) – 20 h treatment. S. a., Staphylococcus aureus; A. b., Acinetobacter baumannii; E. c.,
Escherichia coli.
the interacting bacterial proteins. Cytosolic and membrane
fractions of E. coli were incubated with NCR247C-X2-StrepII or
with StrepII, serving as a control for identification of proteins
binding to the StrepII tag. The protein complexes were purified
with affinity chromatography using Strep-Tactin Sepharose
beads and the eluted proteins were identified with mass
spectrometry (MS) (Supplementary Table S2) and visualized
by gel electrophoresis and silver staining (Figure 2). Numerous
cytosolic proteins showed interaction with NCR247C-X2. They
were predominantly ribosomal proteins that corresponded to
the full list of ribosomal proteins identified previously as
binding partners of NCR247-StrepII in the symbiotic partner
Sinorhizobium meliloti (Farkas et al., 2014). These proteins
ordered from the highest number of peptide counts by the MS
analysis were the followings: L15, S5, S7, L4, L2, L9, L17, S4,
L1, L3, L22, S9, S6, S13, S14, S3, L16, S19, L18, L13, L10, S18,
FIGURE 2 | SDS-gel electrophoresis of proteins eluted from Strep-Tactin
Sepharose column. E2, E3: 2nd and 3rd elution fractions. M: molecular weight
markers.
S12, S28 (Supplementary Table S2). In addition, factors involved
in ribosome maturation or RNA degradation (DeaD, Rne, Pnp,
Hfq, Rnr, RhlE), in translation (InfC), in transcriptional and
translational control (HupB, IhfA, IhfB, CsrA, RmF) including
the RNA polymerase subunits (RpoA, RpoB, RpoC) were present
in the NCR247C-X2-StrepII complexes (Figure 3A). FtsZ, a
major binding partner of NCR247 and essential for the formation
of the Z-ring and cell division, was represented with low peptide
counts in the cytosolic fraction, indicating that the N-terminal
half of NCR247 might contribute to the strong FtsZ binding.
Similarly to FtsZ, MinD septum site-determining protein was
detected with low peptide counts (Figure 3A).
There were fewer interacting partners in the membrane
fraction (Supplementary Table S2) that were outer membrane
components (LpoA, OmpA, OmpF, OmpW, RodZ, DacC, RcsF,
BamA), inner membrane components (ElaB, AtpA, AtpD,
AtpF, HemX, RodZ, FtsH, NuoA) and various efflux pumps
(AcrA-TolC-MacA, MdtE) pumping out the toxic substances or
antibiotics (Figure 3B).
The NCR247-Based Peptides Have No
Cytotoxicity Against Human Cells
Many antibiotics have severe side effects and cytotoxicity;
therefore it was important to test how these plant peptides
affect the integrity and viability of human cells. One of
the simplest and essential assays is to measure hemolysis of
erythrocytes. Hemolysis of human erythrocytes by A–J at 100
and 25 µM concentrations was measured and compared to
the effect of melittin, an AMP from honey bee venom that
induces complete hemolysis at 50 µg/mL. Blood cells without
AMPs in TBS buffer served as negative control (Table 4).
Only transportan showed hemolytic activity, which was 95.6
and 38.6% of the melittin provoked hemolysis at 100 and
25 µM, respectively. Interestingly, the truncated form (I) of
the membranolytic mastoparan lost its hemolytic activity. Only
the chimeric peptides F-H provoked negligible hemolysis at
100 µM. At 25 µM only peptide G had a slight and insignificant
hemolytic activity.
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FIGURE 3 | Interaction of NCR247C-X2-StrepII with Escherichia coli cytosolic and membrane proteins. (A) STRING representation of the cytosolic interacting
proteins excluding the ribosomal proteins and other proteins involved in translation. The color of nodes indicates the following functions: red, RNA metabolic
process; yellow, RNA catabolic process; blue, negative regulators; green, RNA polymerase; purple, translation regulation. The connecting lines indicate the
interactions. (B) STRING representation of the interacting membrane proteins. Protein functions are indicated with different colors. The color of nodes indicate
different functions: blue, ATP metabolic process; magenta, electron transport chain; red, porin activity; green, proton transport; yellow, inner membrane component
and purple, outer membrane components.
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TABLE 4 | NCR247 and its derivatives do not provoke hemolysis.
AMP 100 µM OD560 AVE ± SD RHA%
A 0.02 ± 0.004 1.75
B 0.01 ± 0.002 0.88
C 0.02 ± 0.002 1.75
D 0.04 ± 0.019 3.51
E 0.04 ± 0.008 3.51
F 0.08 ± 0.033 7.02
G 0.13 ± 0.004 11.40
H 0.07 ± 0.004 6.14
I 0.02 ± 0.004 1.75
J 1.09 ± 0.004 95.61
Melittin 1.14 ± 0.364 100
AMP 25 µM OD560 AVE ± SD RHA%
A 0.01 ± 0.008 0.88
B 0.01 ± 0.002 0.88
C 0.02 ± 0.000 1.75
D 0.02 ± 0.017 1.75
E 0.02 ± 0.001 1.75
F 0.02 ± 0.012 1.75
G 0.07 ± 0.002 6.14
H 0.02 ± 0.002 1.75
I 0.01 ± 0.001 0.88
J 0.44 ± 0.131 38.60
Melittin 1.14 ± 0.364 100
Desintegration of red blood cells treated with 100 and 25 µM of AMPs A-J and melittin (50 µg/ml) was measured at OD560. Average OD560 ± standard deviation
(OD560AVE ± SD) and the relative hemolytic activities (RHA) are presented in % of the 100% hemolytic effect of melittin.
In addition we tested the cytotoxicity of peptides X1-
NCR247C and NCR247C-X2 on the viability of A375 human
melanoma cells using the XTT cell proliferation assay (Figure 4).
Conversion of XTT to formazan by metabolically active cells
did not show differences between the control and the X1-
NCR247C treated samples. Similarly NCR247C-X2 exhibited no
cytotoxicity up to 12.5 µM, though slight decrease of the viable
cell number was observed at 25 µM, which concentration is
significantly higher than the MBC values. These data indicate that
X1-NCR247C and NCR247C-X2 in the range of MBCs do not
affect the viability and proliferation of this cell culture.
DISCUSSION
Based on the definitive loss of cell division ability of the nitrogen
fixing bacteroids in M. truncatula root nodules, it is expected
that at least a fraction of the ∼700 NCR peptides can inhibit
bacterial cell division and act as antimicrobial agents in vitro.
Indeed, in our previous studies we have shown the bactericidal
action of several cationic NCR peptides (Van de Velde et al.,
2010; Tiricz et al., 2013; Farkas et al., 2014; Mikuláss et al., 2016;
Farkas et al., 2017; Farkas et al., 2018). Among them, the mode of
action is the best known for NCR247 (Haag et al., 2012; Farkas
et al., 2014; Penterman et al., 2014; Arnold et al., 2017). This
peptide has numerous advantageous properties, it acts very fast,
it has extreme protein binding ability and has many bacterial
targets in the cytosol, by binding to FtsZ it abolishes bacterial
cell division and by interacting with many ribosomal proteins it
inhibits protein synthesis. Due to its multi hit mechanism, the
probability of development of resistant bacteria against NCR247
is very low. A further advantage is that NCR247 is not cytotoxic
for human cells.
In this work we show that NCR247 is capable of killing
several, but not all of the most problematic bacteria causing
incurable infections. Therefore, we aimed to further improve its
bactericidal properties. Testing the antimicrobial activity of the
synthetic N-terminal and C-terminal halves of NCR247 revealed
that antimicrobial activity resided mostly in the C-terminal
region (NCR247C). While the positive charge of the AMPs is
essential for killing, in the case of NCR247C the increased positive
charge (pI = 11.50) did not result in the improvement of the
antimicrobial activity or the antimicrobial spectrum compared
to NCR247 (pI = 10.15). NCR247C had even a much weaker
antimicrobial activity which may be due to the lack of its
proper folding as a result of its short length and/or to its
failure to interact with the bacterial membranes. Adding the
neutral StrepII tag to the NCR247C peptide improved slightly the
antibacterial properties. Extending the N-terminus of NCR247C
with the 13 amino acid long cationic peptide from NCR335
(D) increased the pI to 11.99 and resulted in significantly lower
MBCs (1.6–12.5 µM) and broader spectrum; killing all the eight
bacterium strains. Addition of the truncated mastoparan (lacking
the first three N-terminal amino acids) either to the N- or the
C-terminus of the NCR247C (F, H) increased in similar extent the
antimicrobial properties. Further prolongation of the chimeric
peptides with the StrepII tag (G) increased even more the activity
reaching 1.6–3.1 µM of MBC on all bacteria except for E. faecalis
(MBC 12.5 µM). The killing by the chimeric peptides was instant
(approx. 0.1 min) or very fast (max 5 min) while the complete
killing by the levofloxacin required more than 60 min and the
carbenicillin acted even slower. In addition to the antibiotics’
slower killing kinetics, very high doses (up to 10240 µM) were
required from carbenicillin for the elimination of the tested
bacteria. The MBC values of levofloxacin was more comparable
to chimeric peptides (D-H), acting on S. aureus, A. baumannii,
P. aeruginosa, E. coli, and S. enterica in the same concentration
range but being somewhat less active on K. pneumoniae and
L. monocytogenes and E. faecalis. Importantly the chimeric
peptides maintained their activity also in Mueller Hinton Broth
where cationic AMPs are usually inactivated by the presence of
bivalent cations (Ca2+, Mg2+), which prevent their interaction
with the bacterial membranes (Hancock and Sahl, 2006).
In the chimeric peptide G, the advantageous properties of
NCR247C and mastoparan were combined and the StrepII tag
in addition made possible the identification of the interacting
partners in E. coli using pull-down experiments coupled
to mass spectrometry. NCR247 showed strong interaction
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FIGURE 4 | Viability of human melanoma cell line A375 treated with (A) X1-NCR247C or (B) NCR247C-X2. Relative absorbance values represent the viability
compared to untreated cells. Bar graphs represent mean ± SD values.
with many ribosomal proteins, FtsZ and GroEL of the
symbiotic bacterium partner Sinorhizobium meliloti (Farkas
et al., 2014). The hybrid G peptide interacted with many
E. coli proteins. Ribosomal proteins represented the large
majority of cytosolic partners in agreement with the list of
ribosomal proteins interacting with NCR247 and confirmed
that NCR247C is responsible for binding of ribosomal proteins.
Even if NCR247 has an extreme protein binding ability,
it is unlikely that all these proteins are primary partners.
Nevertheless, interaction with a few ribosomal proteins can be
sufficient to inhibit translation and prevent the development of
resistance. Already several ribosome-targeting peptide antibiotics
are known which interact with different subunits, various
ribosomal proteins and can effect initiation, elongation cycle,
termination and recycling during protein synthesis (Polikanov
et al., 2018). However, none of these peptides have such a
broad interaction with the translation machinery as the NCR247-
based peptides.
FtsZ was detected among the binding partners of peptide
G, however, FtsZ was identified with lower peptide counts;
nevertheless the interaction with FtsZ and MinD might
collectively contribute to abolishment of bacterial cell division.
Interestingly, GroEL playing essential roles in symbiosis was not
found among the E. coli binding partners.
Mastoparan is a membranolytic 14-residue peptide toxin,
which interacts with membranes and adopts amphipathic
α-helical structure in lipid environment, capable of penetrating
biological membranes and causing permeabilization of both
bacterial and mammalian membranes culminating in cell
lysis (Moreno and Giralt, 2015; Irazazabal et al., 2016).
Unexpectedly, by the loss of the first three amino acids, the
truncated mastoparan (X2) did not provoke hemolysis but
accordingly lost much of its antimicrobial activity. Fusing X2
with NCR247C provoked synergistic effect, greatly improving
the antimicrobial efficacy. The pull down with NCR247C-X2-
StrepII identified several outer membrane and inner membrane
components that probably bind to the X2 region of the
chimeric peptide. Among them are various efflux pumps,
pumping out the toxic substances or antibiotics (Amaral et al.,
2014). Attachment of X1 to NCR247C enhanced similarly the
antimicrobial properties.
In summary, we successfully designed and generated from the
symbiotic antimicrobial plant peptide NCR247 several chimeric
peptides with fast killing action, low MBC values, and numerous
bacterial targets without toxicity on human cells. These peptides
represent an extremely promising novel generation of highly
powerful antimicrobial candidates.
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